Effects of sex steroids and growth factors on migration and invasion of endometrial adenocarcinoma SNG-M cells in vitro

Japanese Journal of Cancer Research

Volumn 87, Issue 5, 1996, Pages 524-533

  Ueda, Masatsugu ^a   Fujii, Hideji ^b   Yoshizawa, Keiko ^b   Abe, Fuminori ^b   Ueki, Minoru ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b NIPPON KAYAKU CO LTD   (Japan)

Author keywords

Endometrial adenocarcinoma; Invasion; Matrix metalloproteinase; Migration

Indexed keywords

COLLAGENASE; DANAZOL; EPIDERMAL GROWTH FACTOR; ESTRADIOL; GROWTH FACTOR; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; SEX HORMONE; STROMELYSIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CELL INVASION; CELL MIGRATION; DEGRADATION; ENDOMETRIUM CARCINOMA; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL;

EID: 0030003273     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb00255.x     Document Type: Article

References (41)

1. Fidler, I. J., Gersten, D. M. and Hart, I. R. The biology of cancer invasion and metastases. Adv. Cancer Res., 28, 149-250 (1978).
2. Liotta, L. A., Rao, C. V. and Barsky, S. H. Tumor invasion and the extracellular matrix. Lab. Invest., 49, 636-649 (1983).
3. McCarthy, J. B., Basara, M. L., Palm, S. L., Sas, D. F. and Furcht, L. T. The role of cell adhesion proteins - laminin and fibronectin - in the movement of malignant and metastatic cells. Cancer Metastasis Rev., 4, 125-152 (1985).
4. Nicolson, G. L. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res., 47, 1473-1487 (1987).
5. Poste, G. and Fidler, I. J. The pathogenesis of cancer metastasis. Nature, 283, 139-146 (1979).
6. Werb, Z. Proteinases and matrix degradation. In "Textbook of Rheumatology," ed. W. N. Kelly, E. D. Harris, Jr., S. Ruddy and C. B. Sledge, pp. 300-321 (1989). Saunders, Philadelphia.
7. Woessner, J. F. J. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J., 5, 2145-2154 (1991).
8. Tryggvason, K., Hoyhtya, M. and Salo, T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochem. Biophys. Acta, 907, 191-217 (1987).
9. Matrisian, L. M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet., 6, 121-125 (1990).
10. Liotta, L. A., Steeg, P. S. and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336 (1991).
11. Dickson, R. B. and Lippman, M. E. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrinol. Rev., 8, 29-43 (1987).
12. Mukku, V. R. and Stancel, G. M. Regulation of epidermal growth factor receptor by estrogen. J. Biol. Chem., 260, 9820-9824 (1985).
13. Bulletti, C., Jasonni, V. M., Polli, V., Cappuccini, F., Galassi, A. and Flamigni, C. Basement membrane in human endometrium: possible role of proteolytic enzymes in developing hyperplasia and carcinoma. Ann. N. Y. Acad. Sci., 622, 376-382 (1991).
14. Yoshida, K., Tsujino, T., Yasui, W., Kameda, T., Sano, T., Nakayama, H., Toge, T. and Tahara, E. Induction of growth factor-receptor and metalloproteinase genes by epidermal growth factor and/or transforming growth factor-α in human gastric carcinoma cell line MKN-28. Jpn. J. Cancer Res., 81, 793-798 (1990).
15. Yoshida, K., Yokozaki, H., Niimoto, M., Ito, H., Ito, M. and Tahara, E. Expression of TGF-β and procollagen type I and type III in human gastric carcinomas. Int. J. Cancer, 44, 394-398 (1989).
16. Keski-Oja, J., Raghow, R., Sawdey, M., Loskutoff, D. J., Postlethwaite, A. E., Kang, A. H. and Moses, H. L. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-β. J. Biol. Chem., 263, 3111-3115 (1988).
17. Keski-Oja, J., Blasi, F., Leof, E. B. and Moses, H. L. Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-β. J. Cell Biol., 106, 451-459 (1988).
18. Ishiwata, I., Nozawa, S., Inoue, T. and Okumura, H. Development and characterization of established cell lines from primary and metastatic regions of human endometrial adenocarcinoma. Cancer Res., 37, 1777-1785 (1977).
19. Yamada, T., Ueda, M., Otsuki, Y., Ueki, M. and Sugimoto, O. Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary. Gynecol. Oncol., 40, 118-128 (1991).
20. McCarthy, J. B. and Furcht, L. T. Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro. J. Cell Biol., 98, 1474-1480 (1984).
21. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M. and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47, 3239-3245 (1987).
22. Burk, R. R. A factor from a transformed cell line that affects cell migration. Proc. Natl. Acad. Sci. USA, 70, 369-372 (1973).
23. Heussen, C. and Dowdle, E. B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem., 102, 196-202 (1980).
24. McGuire, W. L., Horwitz, K. B., Pearson, O. H. and Segaloff, A. Current status of estrogen and progesterone receptors in breast cancer. Cancer, 39, 2934-2947 (1977).
25. Lott, J. A., Stephan, V. A. and Pritchard, K. A. Evaluation of the Coomassie Brilliant Blue G-250 method for urinary protein. Clin. Chem., 29, 1946-1950 (1983).
26. Ueda, M., Ueki, M. and Sugimoto, O. Characterization of epidermal growth factor (EGF) receptor and biological effect of EGF on human uterine cervical adenocarcinoma cell line OMC-4. Hum. Cell, 6, 218-225 (1993).
27. Leake, R., Carr, L. and Rinaldi, F. Autocrine and paracrine effects in the endometrium. Ann. N.Y. Acad. Sci., 622, 145-148 (1991).
28. Jasonni, V. M., Bulletti, C., Balducci, M., Naldi, S., Martinelli, G., Galassi, A. and Flamigni, C. The effect of progestin on factors influencing growth and invasion of endometrial carcinoma. Ann. N.Y. Acad. Sci., 622, 463-468 (1991).
29. Yudoh, K., Matsui, H., Kanamori, M., Maeda, A., Ohmori, K. and Tsuji, H. Effects of epidermal growth factor on invasiveness through the extracellular matrix in high- and low-metastatic clones of RCT sarcoma in vitro. Jpn. J. Cancer Res., 85, 63-71 (1994).
30. Poole, A. R., Tutman, K. J., Recklies, A. D. and Stoker, T. A. Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature, 273, 545-547 (1978).
31. Recklies, A. D., Mort, J. S. and Poole, A. R. Secretion of a thiol proteinase from mouse mammary carcinomas and its characterization. Cancer Res., 42, 1026-1032 (1982).
32. Sloane, B. F., Honn, K. V., Sadler, J. C., Turner, W. A., Kimpson, J. J. and Taylor, J. D. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res., 42, 980-986 (1982).
33. Robertson, D. M. and Williams, D. C. In vitro evidence for neutral collagenase activity in an invasive mammalian tumor. Nature, 221, 259-260 (1969).
34. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M. and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature, 284, 67-68 (1980).
35. Dano, K., Andreasen, P. A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L. S. and Skriver, L. Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res., 44, 139-266 (1985).
36. Mori, Y., Mizuuchi, H., Sato, K., Okamura, N. and Kudo, R. The factors involved in invasive ability of endometrial carcinoma cells. Acta Obstet. Gynaecol. Jpn., 46, 509-516 (1994).
37. Nishida, M., Kasahara, K., Kaneko, M., Iwasaki, H. and Hayashi, K. Establishment of a new human endometrial adenocarcinoma cell line, containing estrogen and progesterone receptors. Acta Obstet. Gynaecol. Jpn., 37, 1103-1111 (1985).
38. Nakajima, M. and Chop, A. M. Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. Semin. Cancer Biol., 2, 115-127 (1991).
39. Kauppila, A., Isotalo, H., Kivinen, S., Stenbäck, F. and Vihko, R. Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17β-hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma. Int. J. Cancer, 35, 157-163 (1985).
40. Ikegami, H., Terakawa, N., Shimizu, I., Kano, H., Tanaka, Y., Aono, T., Tanizawa, O. and Matsumoto, K. Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitro. Am. J. Obstet. Gynecol., 155, 857-861 (1986).
41. Liotta, L. A., Goldfarb, R. H., Brundage, R., Siegal, G. P., Terranova, V. and Garbisa, S. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res., 41, 4629-1636 (1981).